Literature DB >> 28695163

Influence of Socioeconomic and Cultural Factors on Retinoblastoma Management.

Bhavna Chawla1,2, Kiran Kumar1,2, Arun D Singh3,4.   

Abstract

Entities:  

Year:  2017        PMID: 28695163      PMCID: PMC5473088          DOI: 10.4103/apjon.apjon_19_17

Source DB:  PubMed          Journal:  Asia Pac J Oncol Nurs        ISSN: 2347-5625


× No keyword cloud information.
Retinoblastoma (RB) is the most common intraocular malignancy of childhood. It contributes to 4% of all pediatric cancers.[1] The incidence of RB is 1 in 15,000–18,000 live births.[2] According to the data published recently by the American Cancer Society, 280 new cases of RB have registered annually in the USA.[3] The age-adjusted incidence rate (<5 years) in the USA is 4.2 per million population (under 15 years).[4] Two decades ago, according to the Bombay Cancer Registry, the incidence in India was more or less similar to that in the developed countries, with 4.2 cases per million population in <15 years age group.[5] However, over the last two decades, the number of cases has increased, possibly due to increased awareness, accessibility to health facilities, and better diagnostic tools. According to a recent report, about 1600–1800 new cases are diagnosed in India every year.[6] RB is a potentially curable tumor with high survival rates if treated early and appropriately. With the advent of improved focal therapy, local routes of drug delivery, and multimodal therapy for orbital RB, the survival with RB has improved dramatically. Other factors that have improved survival are increasing awareness, early diagnosis, and timely referral to specialized care centers. Although overall survival rates have improved, there is still a huge gap in survival rates between the developed and the developing nations. One major factor for this is the stage at presentation. In developing nations, advanced disease contributes to 30%–40% of all cases, whereas in developed nations, only 2%–5% cases of RB have advanced disease. Hence, the survival rates are as high as 90%–99% in the developed nations[78] while only 50% of children with RB survive worldwide.[891011] Several socioeconomic factors contribute to advanced stage at presentation due to delay in diagnosis, lack of access to healthcare facilities, ignorance about early signs, illiteracy, poverty, lack of trained personnel, and inadequate infrastructure. Cultural factors also influence treatment decisions and their uptake.

Socioeconomic Factors

Various studies have shown that patients with a lower socioeconomic status were less likely to receive the recommended therapy and experience less favorable outcomes as compared to those with a higher socioeconomic status.[12] Some of the ways in which socioeconomic status affects treatment and prognosis are as follows: Due to economic constraints, parents from low socioeconomic strata are unable to travel to a specialized center in the early stages of disease, resulting in disease progression, with resultant worsening prognosis Appropriate treatment may not be accessible due to scarcity of human resources, unavailability of appropriate diagnostic skills and instrumentation, essential medication, and lack of support from government and nongovernmental organizations (NGOs) Prolonged treatment protocols that require lengthy stay away from home are another deterrent. Registry-based studies have shown that survival after childhood cancer depends on the resources of the families. The presence of siblings may affect patient care as parents can devote less time in assisting a sick child and there is also less to spend on each child, thereby increasing the chances of comorbidities before and after diagnosis[78] Few specialized centers have the facility for treatment and these are also located only in the big cities, away from rural areas and smaller towns Socioeconomic status also has an influence on the level of education. Parents with a lower status have limited information regarding the signs and symptoms of RB. Parents often state that even though they noted an abnormality in the eye, most often the white reflex, they did not relate this to the possibility of having a life-threatening disease. On the other hand, parents with a higher educational level have a better level of overall health literacy and awareness Comorbidities are more prevalent in children from lower socioeconomic strata due to lack of immunization, respiratory infections, malnutrition, and other factors that further compromise the overall survival rate.

Cultural Beliefs

These are also likely to influence treatment decisions as follows: Due to advanced disease at presentation, enucleation is the most commonly offered treatment. Often, it is not accepted due to unfounded fear of cosmetic disfigurement. This is especially true for a female child, where the cosmetic disability may hinder marital prospects Alternative systems of medicine such as Ayurveda and Homeopathy are quite popular and on many occasions, they are preferred over the cosmetically disfiguring surgery of enucleation Gender-preferential treatment – If the affected child is a male, the family is more willing to borrow for travel and treatment. On the other hand, the female child is often a victim of neglect. Although there is no gender predilection for development of RB, in a recently published study from our center, 60% of children were males, suggesting that parents are more likely to seek tertiary care services for boys than for girls Case studies of defaulters from our center who later progressed to more advanced disease suggest that socioeconomic and/or cultural factors served as deterrents in following medical advice [Table 1].
Table 1

Specific case studies of defaulters due to socioeconomic and/or cultural factors

Age (years)SexDiagnosis at presentationAdviceDuration of follow-up (months)Status at next visitSocioeconomic/cultural factors

ODOS
4FemaleGroup E RB*WNLOD-enucleation10Extraocular RB ODFemale childStigma for enucleationCosmesisIlliteracyPreference for alternative medicine
4FemaleGroup B RB*WNLSystemic chemotherapy Focal therapy7Group E RB* ODLengthy duration of treatmentPovertyLong distance of travelFemale child
5FemaleGroup D RB*EnucleatedSystemic chemotherapy Focal therapy4Extraocular RB ODFemale childPovertyLengthy duration of treatmentIlliteracy
2MaleGroup B RB*EnucleatedSystemic chemotherapy Focal therapy8Extraocular RB ODIlliteracyLong distance of travelPreference for alternative medicine
3MaleWNLGroup E RB*OS-enucleation6Extraocular RB with lymph node invasionStigma for enucleationPreference for alternative medicine

*The International Classification System for Intraocular RB. RB: Retinoblastoma, WNL: Within normal limit, OD: Right eye, OS: Left eye

Specific case studies of defaulters due to socioeconomic and/or cultural factors *The International Classification System for Intraocular RB. RB: Retinoblastoma, WNL: Within normal limit, OD: Right eye, OS: Left eye

Overcoming the Barriers

Some steps that have been taken to overcome these barriers include as follows: Funding support: As the largest tertiary care referral center in India, 250–300 cases of RB are diagnosed every year. The majority of our patients are from low socioeconomic strata and rural background, reflecting the overall population demographics. The majority travel large distances for treatment. With the help of support from governmental agencies and NGOs, we have developed a model that enables free of cost treatment to the poor patients. This includes surgery, hospital stay, focal therapy, chemotherapy, and investigations. In addition, travel and logistics support are also provided. Due to efforts in this direction, the compliance toward treatment has improved drastically and abandonment rates have dropped significantly Multidisciplinary team: Treatment of RB requires close coordination between several disciplines of medicine. A team of specialists consisting of ocular oncologist, pediatric oncologist, radiation oncologist, anesthetist, radiologist, pathologist, geneticist, and nurses works together so that the desired treatment is completed under one roof. This also helps improve patient compliance and reduces the cost Counseling: Proper counseling plays a very important role in overcoming these barriers. Counseling of parents about the nature of the disease, importance of early treatment, available treatment options, morbidity associated with the treatment which may include visual impairment and cosmetic deformity secondary to enucleation or irradiation of the orbital region, and the need for regular follow-up is important. Nursing staff and social workers play an important role in counseling the patients and motivating them. At our center, we have a dedicated social worker and staff nurse for patients with RB who track patient's follow-up by contacting the families by phone before appointment and if they do not return for their scheduled appointment. This has resulted in a significant decrease in dropouts after initiation of treatment.[13]

What More Can Be Done?

RB has a definite recognizable early stage, where focal therapy and/or chemotherapy alone suffice. Sensitizing ophthalmologists and pediatricians toward detection of this vital sign must be undertaken. Linking the “red reflex test” with the national immunization program can go a long way in screening children and identifying them A nationwide awareness campaign to educate the public and healthcare professionals about early signs of RB is required.[13] Early detection of RB and appropriate referral to specialized centers will help in proper treatment and follow-up of these cases The use of telemedicine for continuing education and consultation[14] Identification of a modern center that could mentor other centers using a twinning model, wherein there is a direct and continuous interaction between peripheral hospitals and a specialized center through education, training, and telemedicine[15] Improving the infrastructure and imparting specific training to postgraduate doctors and primary physicians[16] Global initiatives by NGOs such as the International Network for Cancer Treatment and Research, Orbis International, and the International Agency for Prevention of Blindness should be encouraged Creation of facilities for diagnosing and treating RB at the primary and secondary levels of health care can help reduce mortality and morbidity.[7]

Summary

RB accounts for a high tumor burden in developing countries, and the prognosis is closely related to the socioeconomic and cultural profile of the population. Socioeconomic and cultural factors directly affect disease progression and final treatment outcomes. These barriers can be overcome to a certain extent by improving awareness about the disease, proper counseling of parents, providing free of cost treatment to patients from low socioeconomic strata, and raising funds by involving governmental NGOs.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  12 in total

1.  Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area.

Authors:  Scott C Howard; Marcia Pedrosa; Mecneide Lins; Arli Pedrosa; Ching-Hon Pui; Raul C Ribeiro; Francisco Pedrosa
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

2.  Retinoblastoma incidence in the United States.

Authors:  D H Abramson
Journal:  Arch Ophthalmol       Date:  1990-11

3.  Clinical presentation and survival of retinoblastoma in Indian children.

Authors:  Bhavna Chawla; Fahmi Hasan; Rajvardhan Azad; Rachna Seth; Ashish Datt Upadhyay; Sushmita Pathy; R M Pandey
Journal:  Br J Ophthalmol       Date:  2015-06-10       Impact factor: 4.638

4.  Impact of telemedicine on pediatric neuro-oncology in a developing country: the Jordanian-Canadian experience.

Authors:  Ibrahim Qaddoumi; Asem Mansour; Awni Musharbash; James Drake; Maisa Swaidan; Tarik Tihan; Eric Bouffet
Journal:  Pediatr Blood Cancer       Date:  2007-01       Impact factor: 3.167

5.  Improving outcomes for children with cancer in low-income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part I.

Authors:  Scott C Howard; Marco Marinoni; Luis Castillo; Miguel Bonilla; Gianni Tognoni; Sandra Luna-Fineman; Federico Antillon; Maria Grazia Valsecchi; Ching-Hon Pui; Raul C Ribeiro; Alessandra Sala; Ronald D Barr; Giuseppe Masera
Journal:  Pediatr Blood Cancer       Date:  2007-03       Impact factor: 3.167

6.  Retinoblastoma: An Epidemiological Appraisal with Reference to a Population in Mumbai, India.

Authors:  Balkrishna Bhika Yeole; SH Advani
Journal:  Asian Pac J Cancer Prev       Date:  2002

7.  A multicentre report from the Mexican Retinoblastoma Group.

Authors:  C Leal-Leal; M Flores-Rojo; A Medina-Sansón; F Cerecedo-Díaz; S Sánchez-Félix; O González-Ramella; F Pérez-Pérez; R Gómez-Martínez; A Quero-Hernández; E Altamirano-Alvarez; F Alejo-González; J Figueroa-Carbajal; A Ellis-Irigoyen; I Tejocote-Romero; R Cervantes-Paz; F Pantoja-Guillén; L Vega-Vega; F Carrete-Ramírez
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

Review 8.  Diagnosis and management of retinoblastoma.

Authors:  Carol L Shields; Jerry A Shields
Journal:  Cancer Control       Date:  2004 Sep-Oct       Impact factor: 3.302

9.  Trends in eye cancer mortality among children in Brazil, 1980-2002.

Authors:  Karina de Cássia Braga Ribeiro; Célia Beatriz Gianotti Antoneli
Journal:  Pediatr Blood Cancer       Date:  2007-03       Impact factor: 3.167

10.  Team management, twinning, and telemedicine in retinoblastoma: a 3-tier approach implemented in the first eye salvage program in Jordan.

Authors:  Ibrahim Qaddoumi; Ibrahim Nawaiseh; Mustafa Mehyar; Bassem Razzouk; Barrett G Haik; Saamir Kharma; Imad Jaradat; Carlos Rodriguez-Galindo; Matthew W Wilson
Journal:  Pediatr Blood Cancer       Date:  2008-08       Impact factor: 3.167

View more
  6 in total

1.  High-Risk Histopathologic Features of Retinoblastoma Treated at a Tertiary Hospital in West Java, Indonesia.

Authors:  Nur Melani Sari; Regina Hadiputri; Maya Sari Kuntorini; Hasrayati Agustina; Friska Mardianty
Journal:  Ocul Oncol Pathol       Date:  2021-07-20

2.  Role of ethnicity and socioeconomic status (SES) in the presentation of retinoblastoma: findings from the UK.

Authors:  Rabia Bourkiza; Phillippa Cumberland; Ido Didi Fabian; Hiranya Abeysekera; Manoj Parulekar; Mandeep S Sagoo; Jugnoo Rahi; M Ashwin Reddy
Journal:  BMJ Open Ophthalmol       Date:  2020-05-15

3.  The Effects of Breastfeeding on Retinoblastoma Development: Results from an International Multicenter Retinoblastoma Survey.

Authors:  Jasmeen K Randhawa; Mary E Kim; Ashley Polski; Mark W Reid; Kristen Mascarenhas; Brianne Brown; Ido Didi Fabian; Swathi Kaliki; Andrew W Stacey; Elizabeth Burner; Caitlin S Sayegh; Roy A Poblete; Xunda Ji; Yihua Zou; Sadia Sultana; Riffat Rashid; Sadik Taju Sherief; Nathalie Cassoux; Juan Garcia; Rosdali Diaz Coronado; Arturo Manuel Zapata López; Tatiana Ushakova; Vladimir G Polyakov; Soma Rani Roy; Alia Ahmad; M Ashwin Reddy; Mandeep S Sagoo; Lamis Al Harby; Nicholas John Astbury; Covadonga Bascaran; Sharon Blum; Richard Bowman; Matthew J Burton; Nir Gomel; Naama Keren-Froim; Shiran Madgar; Marcia Zondervan; Jesse L Berry
Journal:  Cancers (Basel)       Date:  2021-09-24       Impact factor: 6.639

Review 4.  Retinoblastoma in Asia.

Authors:  Mukesh Jain; Duangnate Rojanaporn; Bhavna Chawla; Gangadhar Sundar; Lingam Gopal; Vikas Khetan
Journal:  Eye (Lond)       Date:  2018-11-01       Impact factor: 3.775

5.  Impact of yoga based lifestyle intervention on psychological stress and quality of life in the parents of children with retinoblastoma.

Authors:  Shilpa Bisht; Bhavna Chawla; Madhuri Tolahunase; Richa Mishra; Rima Dada
Journal:  Ann Neurosci       Date:  2019-04-01

6.  Commentary: The challenges of treating retinoblastoma in India.

Authors:  Parag K Shah
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.